Wells Fargo & Company Creative Medical Technology Holdings, Inc. Transaction History

Wells Fargo & Company

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.37 - $1.04 $0 - $1	1 Added 1.04%	97 $0
Q4 2022 Feb 13, 2023	BUY	$0.35 - $5.17 $1 - $15	3 Added 3.23%	96 $0
Q3 2022 Nov 14, 2022	BUY	$0.55 - $5.07 $18 - $172	34 Added 57.63%	93 $0
Q2 2022 Aug 12, 2022	BUY	$0.62 - $3.66 $14 - $84	23 Added 63.89%	59 $0
Q1 2022 May 16, 2022	BUY	$1.33 - $4.54 $47 - $163	36 New	36 $0

Ticker CELZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,070,300
Market Cap $36.6M
Description
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.